GT Biopharma, Inc.
GTBP· Nasdaq
GTBPGT Biopharma, Inc.
Filed Mar 30, 2016 · 10-K · 90 days after period end · 0001354488-16-006816
derived · Computed from the longer spans the company filed.
| Metric | Q4 2015dderived from reported figures | Q4 2014dderived from reported figures | Q4 2013dderived from reported figures | Q4 2012dderived from reported figures |
|---|---|---|---|---|
| Revenue | $0.00 | $33.00K | — | $220.00K |
| Net Income | -$26.11M | -$18.64M | -$331.00K | -$761.00K |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
GT Biopharma, Inc. · CIK 109657 · Engraved from SEC EDGAR
ended Dec 31, 2015 · filed Mar 30, 2016 · 90 d after period end
